Nuveen Asset Management LLC grew its holdings in Ultralife Co. (NASDAQ:ULBI – Free Report) by 59.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,647 shares of the technology company’s stock after acquiring an additional 8,037 shares during the period. Nuveen Asset Management LLC owned 0.13% of Ultralife worth $161,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in ULBI. IFP Advisors Inc bought a new stake in shares of Ultralife during the 4th quarter valued at $85,000. Northern Trust Corp raised its position in shares of Ultralife by 8.0% during the 4th quarter. Northern Trust Corp now owns 87,633 shares of the technology company’s stock valued at $653,000 after purchasing an additional 6,484 shares during the period. Barclays PLC raised its position in shares of Ultralife by 13.7% during the 4th quarter. Barclays PLC now owns 15,233 shares of the technology company’s stock valued at $113,000 after purchasing an additional 1,838 shares during the period. Connor Clark & Lunn Investment Management Ltd. raised its position in shares of Ultralife by 13.2% during the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 178,170 shares of the technology company’s stock valued at $1,327,000 after purchasing an additional 20,840 shares during the period. Finally, Raymond James Financial Inc. bought a new stake in shares of Ultralife during the 4th quarter valued at $522,000. 30.68% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other news, Director Bradford T. Whitmore purchased 11,980 shares of the company’s stock in a transaction that occurred on Friday, May 23rd. The stock was purchased at an average cost of $5.41 per share, with a total value of $64,811.80. Following the purchase, the director now owns 1,060,067 shares in the company, valued at approximately $5,734,962.47. This trade represents a 1.14% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Thomas Louis Saeli purchased 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average cost of $5.44 per share, with a total value of $27,200.00. Following the completion of the purchase, the director now owns 85,000 shares in the company, valued at $462,400. This trade represents a 6.25% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 47,140 shares of company stock valued at $256,355. Company insiders own 40.00% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Report on ULBI
Ultralife Stock Performance
Shares of NASDAQ:ULBI opened at $7.70 on Friday. Ultralife Co. has a 52 week low of $4.07 and a 52 week high of $12.40. The stock has a market capitalization of $128.07 million, a P/E ratio of 14.00 and a beta of 0.90. The firm has a fifty day simple moving average of $5.20 and a two-hundred day simple moving average of $6.41. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04.
Ultralife (NASDAQ:ULBI – Get Free Report) last issued its quarterly earnings data on Friday, May 9th. The technology company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.02). Ultralife had a return on equity of 7.92% and a net margin of 5.44%. The business had revenue of $50.75 million during the quarter, compared to analysts’ expectations of $54.50 million. During the same period in the previous year, the business earned $0.21 earnings per share.
About Ultralife
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Recommended Stories
- Five stocks we like better than Ultralife
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- A Large Oil Supply Draw Could Mean Upside in These 3 Energy Names
- Stock Sentiment Analysis: How it Works
- 3 Stocks Getting Rare Double Upgrades From Analysts
- Using the MarketBeat Dividend Tax Calculator
- This Banking Giant Just Got a $90 Price Target Upgrade
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.